The BioBridge provides key connections between clinicians, researchers, and industry within the health innovation ecosystems of Australia and New Zealand. This Trans-Tasman collaboration helps spark conversations and build anchored science and business partnerships with long-term strategic benefits for the development of new healthcare technologies and business opportunities.
The BioBridge is hosted by the Auckland Bioengineering Institute at the University of Auckland, on behalf of the CMDT, and the Liverpool Innovation Precinct in Sydney. Stage 1 of the BioBridge project has been funded as an MBIE Catalyst Influence Activities Project from 2020 to 2023.
The BioBridge is open to researchers, clinicians, and companies within the MedTech space; more specifically, in medical devices and digital health.
Researchers across the Tasman have used this platform to develop new partnerships with complementary expertise and knowledge, whilst companies have used this to help identify key opinion leaders and specific business expertise.
Trans-Tasman connections are supported through curated workshops,1:1 meetings, and international delegations.
If you’re interested to learn how the BioBridge can connect you across the Tasman, get in touch to find out more.
Akoranga Take | Case Studies
He was seeking collaborators for health technologies that could be applied to their products so the BioBridge team curated a virtual workshop with select New Zealand academics. We assisted with the follow-up discussions to progress potential collaborations and this led to an MOU with AUT.
Kiriti was also offered the opportunity to speak at and attend HealthTech Week 2022 in a delegation from Australia. The BioBridge team organised a series of meetings whilst in Auckland to continue discussions from the initial workshop also leading to another agreement.
He was offered a place in the delegation to HealthTech Week 2022 to grow these connections. Paul and Vickie are now collaborating on a research proposal.
Founder and CEO Ehsan Vaghefi was interested in connections to commercialisation experts in Australia. Through the BioBridge, Dr Vaghefi was introduced to his now executive director, Gerard Wallace, who has been instrumental in their commercialisation efforts and growth of the company.
Nga Awheawhe O Mua | Previous Workshops
Emerging Technologies for Gut Health
Speakers:
Australia
- Dr Jerry Zhou - Western Sydney University
- Dr Kyle Berean - Atmo Biosciences
New Zealand
- Associate Professor Peng Du, University of Auckland
- Professor Greg O'Grady, Alimetry
Watch the Australia-New Zealand BioBridge workshop to learn about innovative technologies transforming gastroenterology for more personalized care and improved patient outcomes.
Nga Whakahoahoa O Naianei | Current Partnerships
Hoapā Matua | Key Contacts
